The Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory ...

Orthopedic surgeons say the most complicated part of delivering care today is not surgery — it is navigating the administrative layers behind it, from prior authorization hurdles to performance metric ...